Table 2:

Absolute and relative rate of fragility fracture among cases compared with controls*

CharacteristicUnexposedExposedUnadjusted HR (95% CI)Adjusted HR (95% CI)
nRate (95% CI)nRate (95% CI)
Overall716454.7 (53.5–56.0)177052.9 (50.5–55.6)0.97 (0.92–1.02)0.95 (0.89–1.01)
Age, yr (quartile)
168318.3 (16.9–19.7)17918.6 (16.1–21.6)1.02 (0.86–1.20)0.90 (0.73–1.10)
2114732.2 (30.3–34.0)29632.7 (29.2–36.7)1.01 (0.90–1.16)0.92 (0.79–1.07)
3202061.7 (59.1–64.5)50561.7 (56.6–67.4)1.02 (0.92–1.12)1.01 (0.91–1.14)
43314132.4 (127.9–136.9)790119.6 (111.6–128.3)0.92 (0.85–1.00)0.94 (0.86–1.03)
Sex
Male301630.9 (29.4–32.0)79331.5 (29.4–33.8)1.02 (0.94–1.10)0.99 (0.90–1.09)
Female4148124.7 (121.0–128.5)977117.7 (110.5–125.3)0.96 (0.89–1.02)0.94 (0.87–1.01)
  • Note: BMI = body mass index, CI = confidence interval, HR = hazard ratio.

  • * Multiple imputation was used to replace missing values of BMI using a chain equation approach based on all baseline characteristics. Five imputed data sets were created and results were combined across all data sets using the Rubin rule to obtain final estimates.

  • Per 10 000 person-years.

  • Adjusted for age, alcohol consumption, smoking status, BMI, Charlson index, opioids, fall, glucocorticoids, nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, proton pump inhibitors, antidiabetic and antihypertensive agents, and selective serotonin reuptake inhibitors.